首页 › 肾癌（肾细胞癌） › 宾夕法尼亚州 › Pittsburgh
Pittsburgh PA 肾癌（肾细胞癌）临床试验
15项针对 肾癌（肾细胞癌）的研究正在 Pittsburgh及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
招募中1 期
- Research Site, Pittsburgh
A Phase 1 Study of the Safety and Tolerability of CTX-10726
招募中1 期
- UPMC Hillman Cancer Center, Pittsburgh
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
招募中1/2 期
- UPMC Cancer Center/Hillman Cancer Center ( Site 5017), Pittsburgh
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #32, Pittsburgh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
- 以及另外 2 项
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
招募中2 期
- Allegheny General Hospital, Pittsburgh
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- 以及另外 14 项
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
招募中3 期
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
- 以及另外 3 项
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
招募中1/2 期
- Research Site, Pittsburgh
Autologous Dendritic Cell Vaccine in Kidney Cancer
招募中2 期
- UPMC Department of Urology, Pittsburgh
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
招募中1 期
- UPMC Hillman Cancer Center, Pittsburgh
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
招募中1 期
- UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
招募中1/2 期
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
招募中2 期
- UPMC Hillman Cancer Center, Pittsburgh
A Study of VET3-TGI in Patients With Solid Tumors
招募中1 期
- UPMC- Hillman Cancer Center, Pittsburgh
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
招募中3 期
- UPMC-Saint Margaret, Pittsburgh
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- UPMC-Shadyside Hospital, Pittsburgh
- 以及另外 9 项
其他城市的 肾癌（肾细胞癌）试验
- Houston, TX35 项研究
- New York City, NY27 项研究
- Dallas, TX23 项研究
- Nashville, TN23 项研究
- St. Louis, MO23 项研究
- Los Angeles, CA20 项研究
- Boston, MA16 项研究
- Baldwin Park, CA16 项研究
- Philadelphia, PA15 项研究
- Queens, NY15 项研究
- Jacksonville, FL14 项研究
- Rochester, MN14 项研究
Pittsburgh的其他研究
- 非小细胞肺癌48 项研究
- 癌症（所有类型）41 项研究
- 乳腺癌39 项研究
- 结直肠癌32 项研究
- 转移性癌症31 项研究
- 黑色素瘤31 项研究
- 卵巢癌30 项研究
- 子宫内膜癌23 项研究
- 前列腺癌23 项研究
- 肺癌23 项研究
- 头颈鳞状细胞癌22 项研究
- 卒中22 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。